Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-05-10

Clinical Trial Update: Efficacy and Safety of a Retinoid for the Treatment of Severe Chronic Hand Dermatitis [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating a retinoid for severe chronic hand dermatitis, focusing on efficacy and safety outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Basilea Pharmaceutica | Conditions: Hand Dermatoses | Phase 3 | Status: COMPLETED